Last reviewed · How we verify
Torasemide Prolonged Release — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Torasemide Prolonged Release (Torasemide Prolonged Release) — Ferrer Internacional S.A..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Torasemide Prolonged Release TARGET | Torasemide Prolonged Release | Ferrer Internacional S.A. | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Torasemide Prolonged Release CI watch — RSS
- Torasemide Prolonged Release CI watch — Atom
- Torasemide Prolonged Release CI watch — JSON
- Torasemide Prolonged Release alone — RSS
Cite this brief
Drug Landscape (2026). Torasemide Prolonged Release — Competitive Intelligence Brief. https://druglandscape.com/ci/torasemide-prolonged-release. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab